Q4 2026 Krishna Institute of Medical Sciences Ltd Earnings Call Transcript
Key Points
- Krishna Institute of Medical Sciences Ltd (BOM:543308) reported a total revenue of INR1,084 crores for Q4 FY26, marking a growth of 35.3% year-on-year and 8.1% quarter-on-quarter.
- The company achieved a significant milestone by completing over 10,000 successful brain tumor surgeries.
- New units in Bangalore, Thane, Kerala, Nashik, and Seethammadhara, Vizag contributed significantly to the top-line growth.
- Operational metrics showed improvement with average revenue per operating bed and per patient growing by 14% and 11.4% year-on-year, respectively.
- The company has been proactive in community health initiatives, such as organizing large-scale blood pressure check-ups to raise awareness about hypertension.
- EBITDA margin decreased to 19.9% in Q4 FY26 from 25.3% in Q4 FY25, indicating a decline in profitability.
- PAT for Q4 FY26 was INR32 crores, significantly lower than INR106 crores in Q4 FY25.
- The company faced challenges with insurance empanelments, causing delays in ramp-up for new units.
- New units are currently operating at a loss, with specific losses reported for Nashik, Thane, and Karnataka units.
- The company's consolidated earnings per share for FY26 declined by 37.2% year-on-year.
Ladies and gentlemen, good day, and welcome to KIMS Hospital Q4 FY26 earnings conference call hosted by IIFL Capital. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Rahul Jeewani. Thank you, and over to you, Mr. Jeewani.
Good morning, everyone. This is Rahul from IIFL Capital. I welcome you all to the fourth quarter earnings conference call of KIMS Hospitals being hosted by IIFL. From KIMS, we have with us today Dr. Bhaskara Rao Bollineni, Founder and Managing Director; Dr. Abhinay Bollineni, Executive Director and CEO; Mr. Sachin Salvi, CFO. Over to you, sir, for your opening comments.
Good morning. Hearty welcome to all of you. The closure of financial year 2026 coincide with the beginning of the ongoing Gulf war with the ramifications across many countries in the world, including India. The
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
